青海春天药用资源科技股份有限公司关于收到中国证券监督管理委员会青海监管局警示函的公告

Core Viewpoint - Qinghai Spring Pharmaceutical Resources Technology Co., Ltd. received a warning letter from the China Securities Regulatory Commission (CSRC) for failing to disclose related party transactions and relationships with Yibin Tinghua Wine Industry Development Co., Ltd. [1][2] Group 1: Regulatory Actions - The CSRC's Qinghai Regulatory Bureau issued a decision to order Qinghai Spring to rectify its actions and warned key individuals including Chairman Zhang Xuefeng and others for their responsibilities in the violations [2][3] - The company is required to correct the violations within 30 days and submit a written rectification report [3] Group 2: Violations and Responsibilities - Qinghai Spring violated multiple provisions of the Information Disclosure Management Measures, including failing to disclose related party relationships and transaction procedures [2] - Key individuals, including the chairman and financial director, are held primarily responsible for these violations [2]